University of California San Francisco
Give to UCSF
Researchers at UCSF have observed a new feature of neural activity in the hippocampus – the brain’s memory hub – that may explain how this vital brain region combines a diverse range of inputs into a multi-layered memories that can later be recalled.
New research by UCSF scientists shows retinal scans can detect key changes in blood vessels that may provide an early sign of Alzheimer’s disease.
Pioneering neural recordings in patients with Parkinson’s disease by UCSF scientists are providing the groundwork for personalized brain stimulation to treat Parkinson’s and other neurological disorders.
Games and supplements claim to strengthen memory and cognition. Should you buy them?
Researchers at UCSF have demonstrated how to engineer smart immune cells that are effective against solid tumors, opening the door to treating a variety of cancers that have long been untouchable with immunotherapies.
Three faculty members from UCSFhave been elected to the National Academy of Sciences (NAS), one of the highest honors accorded to American scientists.
While researchers are still striving to understand why some patients experience these “long-haul” symptoms, two UCSF clinicians from complimentary specialties have teamed up to create an integrative medicine skills program that can give such patients better tools to cope with the debilitating symptoms.
Researchers at UCSF have confirmed that a different, long under-studied type of brain cell – astrocytes, named for their star-like shape – can influence how long and how deeply animals sleep.
The Global Brain Health Institute (GBHI) is delighted to present “UnRavelled,” a new drama by award-winning playwright Jake Broder, which explores the relationship between art, music and brain health.
UCSF and UC Berkeley today announced a long-term research partnership with Genentech, a member of the Roche Group, and its parent company, Roche Holding AG, to speed the development of new therapeutics for debilitating brain diseases and disorders of the central nervous system.
In a new study, UCSF and Stanford researchers have identified a central switch that appears to control when neural progenitor cells stop multiplying and start differentiating into mature neurons.
The new Institute will bring together scientists and clinicians from all UCSF sites to address the most critical questions related to the science of aging.
A new study of autism risk genes by UCSF and UC Berkeley scientists implicates disruption in prenatal neurogenesis – a process in which specialized “progenitor” cells give rise to new brain cells – in the development of autism spectrum disorders.
